title: [The adverse reactions and treatment of fundus fluorescein angiography].
abstract: OBJECTIVE
  To investigate the safety of fluorescein angiography and to evaluate the examination.
  
  
  METHODS
  We retrospectively analyzed 8 344 patients who underwent fluorescein angiography in our hospital in the past four years. The rate of adverse events was calculated and the emergency management for severe cases was discussed.
  
  
  RESULTS
  There were 693 cases (8.3%) of adverse events occurring in the patients. Many of them were mild or moderate ones, which were 664 cases in number and were 7.87% in rate. The other 29 cases (0.35%) were severe ones. No special treatment was needed for the mild or moderate adverse events, the symptoms can be relaxed by deep breathing or having a rest for a moment. The symptoms of the severe adverse events can be relieved through anti-hypersuscepibility treatments and no sequelae left. No case of death occurred.
  
  
  CONCLUSIONS
  The adverse events could occur in fluorescein angiography examination. It suggests that we should pay attention to it and be aware of the system conditions of the patients. It is also important for us to grasp the indications and contraindications and to prepare for the emergent events. In summary, fluorescein angiography is generally a safe method for the examination of fundus disease.
authors.affiliation: Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China.
authors.forename: Guiying
authors.initials: G
authors.lastname: Mai
authors.forename: Hong
authors.initials: H
authors.lastname: Yan
authors.forename: Mei
authors.initials: M
authors.lastname: Li
authors.forename: Jiexiong
authors.initials: J
authors.lastname: Ou
authors.forename: Shunying
authors.initials: S
authors.lastname: Liu
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D004342:Drug Hypersensitivity / Q000175:diagnosis / Q000628:therapy*; D005260:Female; D005451:Fluorescein Angiography / Q000009:adverse effects*; D005452:Fluoresceins / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies
chemical_list: D005452:Fluoresceins